Pirenzia has spent the better part of the last decade developing a new vaccination technology under exclusively licensed patents from the University of South Dakota (USD). We are partnered with Pirenzia to help them prepare their universal flu vaccines for both the human and agricultural markets.
In the next several years, Pirenzia aims to inoculate livestock against multiple flu strains at once. They also hope to halt the swine flu's transmission to humans, which killed 200,000 people in 2009.
We have provided detailed plans for future expansion, investment, and innovation to Pirenzia and our early investments have helped position Pirenzia to become a significant future player in pharmaceutical markets.
Pirenzia is affiliated with two of North America's top agricultural virus experts and a highly experienced medical advisory board. Together, Pirenzia represents decades of collective experience treating viruses, running successful businesses, respected medical practices, and scholarship.
